| Year |
Citation |
Score |
| 2006 |
Madras BK, Fahey MA, Goulet M, Lin Z, Bendor J, Goodrich C, Meltzer PC, Elmaleh DR, Livni E, Bonab AA, Fischman AJ. Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo. The Journal of Pharmacology and Experimental Therapeutics. 319: 570-85. PMID 16885433 DOI: 10.1124/Jpet.106.105312 |
0.638 |
|
| 2004 |
Yang H, Wang L, Wu SV, Tay J, Goulet M, Boismenu R, Czimmer J, Wang Y, Wu S, Ao Y, Taché Y. Peripheral secretin-induced Fos expression in the rat brain is largely vagal dependent. Neuroscience. 128: 131-41. PMID 15450360 DOI: 10.1016/J.Neuroscience.2004.06.027 |
0.303 |
|
| 2004 |
Tay J, Goulet M, Rusche J, Boismenu R. Age-related and regional differences in secretin and secretin receptor mRNA levels in the rat brain. Neuroscience Letters. 366: 176-81. PMID 15276242 DOI: 10.1016/J.Neulet.2004.05.030 |
0.315 |
|
| 2003 |
Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ. Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. European Journal of Pharmacology. 479: 41-51. PMID 14612136 DOI: 10.1016/J.Ejphar.2003.08.055 |
0.648 |
|
| 2002 |
Calon F, Morissette M, Ghribi O, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 127-38. PMID 11853103 DOI: 10.1016/S0278-5846(01)00237-8 |
0.407 |
|
| 2001 |
Goulet M, Miller GM, Bendor J, Liu S, Meltzer PC, Madras BK. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates? Synapse (New York, N.Y.). 42: 129-40. PMID 11746710 DOI: 10.1002/Syn.1108 |
0.67 |
|
| 2001 |
Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter. Synapse (New York, N.Y.). 40: 225-34. PMID 11304760 DOI: 10.1002/Syn.1045 |
0.363 |
|
| 2001 |
Miller GM, Yatin SM, De La Garza R, Goulet M, Madras BK. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Research. Molecular Brain Research. 87: 124-43. PMID 11223167 DOI: 10.1016/S0169-328X(00)00288-6 |
0.66 |
|
| 2000 |
Calon F, Hadj Tahar A, Blanchet PJ, Morissette M, Grondin R, Goulet M, Doucet JP, Robertson GS, Nestler E, Di Paolo T, Bédard PJ. Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends in Neurosciences. 23: S92-100. PMID 11052226 DOI: 10.1016/S1471-1931(00)00026-4 |
0.426 |
|
| 2000 |
Goulet M, Grondin R, Morissette M, Maltais S, Falardeau P, Bédard PJ, Di Paolo T. Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 607-17. PMID 10958154 DOI: 10.1016/S0278-5846(00)00096-8 |
0.43 |
|
| 2000 |
Calon F, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. 125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments. Experimental Neurology. 163: 191-9. PMID 10785458 DOI: 10.1006/Exnr.2000.7366 |
0.404 |
|
| 2000 |
Goulet M, Madras BK. D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys. The Journal of Pharmacology and Experimental Therapeutics. 292: 714-24. PMID 10640310 |
0.571 |
|
| 1999 |
Grondin R, Goulet M, Morissette M, Bédard PJ, Di Paolo T. Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958. European Journal of Pharmacology. 378: 259-63. PMID 10493101 DOI: 10.1016/S0014-2999(99)00482-3 |
0.477 |
|
| 1999 |
Calon F, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content. Neurochemistry International. 35: 81-91. PMID 10403433 DOI: 10.1016/S0197-0186(99)00064-9 |
0.42 |
|
| 1999 |
Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Synapse (New York, N.Y.). 32: 153-64. PMID 10340626 DOI: 10.1002/(Sici)1098-2396(19990601)32:3<153::Aid-Syn2>3.0.Co;2-X |
0.49 |
|
| 1999 |
Morissette M, Grondin R, Goulet M, Bédard PJ, Di Paolo T. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists. Journal of Neurochemistry. 72: 682-92. PMID 9930741 DOI: 10.1046/J.1471-4159.1999.0720682.X |
0.421 |
|
| 1998 |
Morissette M, Goulet M, Grondin R, Blanchet P, Bédard PJ, Di Paolo T, Lévesque D. Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. The European Journal of Neuroscience. 10: 2565-73. PMID 9767387 DOI: 10.1046/J.1460-9568.1998.00264.X |
0.446 |
|
| 1997 |
Morissette M, Goulet M, Soghomonian JJ, Blanchet PJ, Calon F, Bédard PJ, Di Paolo T. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy. Brain Research. Molecular Brain Research. 49: 55-62. PMID 9387863 DOI: 10.1016/S0169-328X(97)00123-X |
0.425 |
|
| 1997 |
Goulet M, Morissette M, Calon F, Blanchet PJ, Falardeau P, Bédard PJ, Di Paolo T. Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis. Neuroscience. 79: 497-507. PMID 9200732 DOI: 10.1016/S0306-4522(96)00689-6 |
0.415 |
|
| 1996 |
Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Molecular Pharmacology. 50: 1073-9. PMID 8913337 |
0.304 |
|
| 1996 |
Grondin R, Goulet M, Di Paolo T, Bédard PJ. Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates. Brain Research. 735: 298-306. PMID 8911668 DOI: 10.1016/0006-8993(96)00597-5 |
0.48 |
|
| 1996 |
Soghomonian JJ, Pedneault S, Blanchet PJ, Goulet M, Di Paolo T, Bédard PJ. L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys. Brain Research. Molecular Brain Research. 39: 237-40. PMID 8804732 DOI: 10.1016/0169-328X(96)00078-2 |
0.34 |
|
| 1996 |
Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys. Brain Research. 719: 129-37. PMID 8782872 DOI: 10.1016/0006-8993(96)00157-6 |
0.438 |
|
| 1995 |
Calon F, Goulet M, Blanchet PJ, Martel JC, Piercey MF, Bédard PJ, Di Paolo T. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex. Brain Research. 680: 43-52. PMID 7663983 DOI: 10.1016/0006-8993(95)00229-J |
0.465 |
|
| Show low-probability matches. |